Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Josef Scheiber"'
Autor:
Hannah Benedictine Maier, Alexandra Neyazi, Gabriel L. Bundies, Fiona Meyer-Bockenkamp, Stefan Bleich, Hansi Pathak, Yvonne Ziert, Barbara Neuhaus, Franz-Josef Müller, Iris Pollmann, Thomas Illig, Stefanie Mücke, Meike Müller, Brinja Kira Möller, Steffen Oeltze-Jafra, Tim Kacprowski, Jan Voges, Fabian Müntefering, Josef Scheiber, Andreas Reif, Mareike Aichholzer, Christine Reif-Leonhard, Maren Schmidt-Kassow, Ulrich Hegerl, Hanna Reich, Stefan Unterecker, Heike Weber, Jürgen Deckert, Nicole Bössel-Debbert, Hans J. Grabe, Michael Lucht, Helge Frieling
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-12 (2024)
Abstract Background Brain-derived neurotrophic factor (BDNF) is essential for antidepressant treatment of major depressive disorder (MDD). Our repeated studies suggest that DNA methylation of a specific CpG site in the promoter region of exon IV of t
Externí odkaz:
https://doaj.org/article/55ea2c6790ba48b2a005ed3270692acc
Autor:
Louisa Hempel, Constantin Lapa, Alexander Dierks, Andreas Gaumann, Josef Scheiber, Julia Veloso de Oliveira, Patrick Philipp, Cristina Oyarzun Laura, Stefan Wesarg, Sebastian Robert, Dirk Hempel
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Point mutations of the fibroblast growth factor receptor (FGFR)2 receptor in intrahepatic cholangiocarcinoma (iCC) are mainly of unknown functional significance compared to FGFR2 fusions. Pemigatinib, a tyrosine kinase inhibitor, is approved for the
Externí odkaz:
https://doaj.org/article/982c38906143430eb4ee3583f4e9e6bd
Autor:
Louisa Hempel, Armin Piehler, Michael W. Pfaffl, Jakob Molnar, Benedikt Kirchner, Sebastian Robert, Julia Veloso, Beate Gandorfer, Zeljka Trepotec, Stefanie Mederle, Sabine Keim, Valeria Milani, Florian Ebner, Katrin Schweneker, Bastian Fleischmann, Axel Kleespies, Josef Scheiber, Dirk Hempel, Dietmar Zehn
Publikováno v:
Cancer Medicine, Vol 9, Iss 21, Pp 8020-8028 (2020)
Abstract Oncologic patients are regarded as the population most at risk of developing a severe course of COVID‐19 due to the fact that malignant diseases and chemotherapy often weaken the immune system. In the face of the ongoing SARS‐CoV‐2 pan
Externí odkaz:
https://doaj.org/article/f3cc74c165004aed92924f75b8b5f8b5
Publikováno v:
Advances in Kidney Disease and Health. 30:47-52
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb3f9e8401c425bcc43cc5d12f9d7dec
https://doi.org/10.1053/j.akdh.2022.11.005
https://doi.org/10.1053/j.akdh.2022.11.005
Autor:
Julien-Tyron Barth, Cornelius Roth, Maike Konrad, Linda Plail, Andreas Ambrosch, Susanne Gastiger, Michael Hubmann, Michael Kabesch, Kristina Schraml, Josef Scheiber, Daniel Wallerstorfer, Christopher Bartl, Andreea Matei, Jakob Niggel, Ezgi Cibali, Thomas Wagner, Catherine M. Sweeney-Reed, Parastoo Kheiroddin, Magdalena Gründl, Patricia Schöberl, Michael Althammer, Heike Buntrock-Döpke, Philipp Pagel, Christin Fetz, Andreas Burkovski, Shabnam Rajabi, Mona Bodenschatz, Claudia Kiesewetter, Andreas Kneissler, Guido Judex
Publikováno v:
COVID; Volume 1; Issue 4; Pages: 717-727
(1) Background: With vaccination and new variants of SARS-CoV-2 on the horizon, efficient testing in schools may enable prevention of mass infection outbreaks, keeping schools safe places and buying time until decisions on feasibility and the necessi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77b961c68e616a1e8e1760fe5577762a
Autor:
Zeljka Trepotec, Jakob Molnar, Armin Piehler, Cordula Schick, Kristina Riedmann, Sofie Englisch, Axel Kleespies, Louisa Hempel, Sebastian Robert, Katrin Schweneker, Josef Scheiber, Julia Veloso, Valeria Milani, Beate Gandorfer, Bastian Fleischmann, Dirk Hempel, Philip Weinzierl
Publikováno v:
Seminars in Oncology
SARS-CoV-2 antibody development and immunity will be crucial for the further course of the pandemic. Until now, it has been assumed that patients who were infected with SARS-CoV-2 develop antibodies as it is the case with other coronaviruses, like ME
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a25c866d7f6996eb1c78c87aff6f2bd7
https://publica.fraunhofer.de/handle/publica/266022
https://publica.fraunhofer.de/handle/publica/266022
Autor:
Armin Piehler, Valeria Milani, Axel Kleespies, Benedikt Kirchner, Stefanie Mederle, Sabine Keim, Bastian Fleischmann, Louisa Hempel, Michael W. Pfaffl, Dietmar Zehn, Florian Ebner, Zeljka Trepotec, Katrin Schweneker, Jakob Molnar, Sebastian Robert, Josef Scheiber, Dirk Hempel, Julia Veloso, Beate Gandorfer
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 21, Pp 8020-8028 (2020)
Cancer Medicine, Vol 9, Iss 21, Pp 8020-8028 (2020)
Oncologic patients are regarded as the population most at risk of developing a severe course of COVID‐19 due to the fact that malignant diseases and chemotherapy often weaken the immune system. In the face of the ongoing SARS‐CoV‐2 pandemic, ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce273fc4b783a912fec18443621ae2eb
Publikováno v:
Journal of Chemical Information and Modeling. 58:165-181
A novel alignment-free molecular descriptor called xMaP (flexible MaP descriptor) is introduced. The descriptor is the advancement of the previously published translationally and rotationally invariant three-dimensional (3D) descriptor MaP (mapping p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::840054d8d2b2c94568bae5dfa4dce0d7
https://doi.org/10.1021/acs.jcim.7b00419
https://doi.org/10.1021/acs.jcim.7b00419
Autor:
Josef Scheiber
Publikováno v:
Expert Opinion on Drug Discovery. 6:219-224
Individualized treatment selection based on scientific results is set to be the future of healthcare. It will not only have a significant favorable impact on the health of patients suffering from various diseases, but also on how drug discovery is pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f20d9a1bd9e3cf26accdf339e85134e
https://doi.org/10.1517/17460441.2011.550279
https://doi.org/10.1517/17460441.2011.550279